Research
Learn About Our Clinical Trials
Clinical trials are carefully designed research studies that answer specific questions about the safety and effectiveness of preventive techniques, medications, treatments, therapies or surgical techniques. Participation in a clinical trial is strictly voluntary.
Many studies that are developed and available are similar to treatments often referred to as the “gold standard.” Advancements in medicine may lead to improved outcomes through improved results, less discomfort, less time involved in treatment, lower cost, and/or improved safety. At Urology Associates, we are very selective about studies that we choose to offer to our patients.
Urology Associates is enrolling patients for clinical trials, in order to help our patients live longer, healthier lives.
Am I eligible?
Many studies have strict enrollment criteria. The list of inclusion and exclusion criteria are different for each study. Our team will assess whether a patient is eligible for a particular study.
The Urology Associates Clinical Research Department is now recruiting for the clinical trials listed below.
Men over 50 – Constantly getting up in the middle of the night to urinate doesn’t just affect sufferers of BPH it affects their partners too. In the past, solutions to bladder issues may have involved long-term medication or even surgical procedures.
If you have symptoms of BPH you may qualify for the Butterfly Medical study, a clinical study to evaluate a new treatment for BPH. The Butterfly is a minimally invasive procedure that can be completed in less than ten minutes.If you qualify to particpate you may receive reimbursement for time and travel.
Interested in participating and want to learn more about enrollment criteria? Email: Research@uradenver.com
Phone: 303-733-8848 ext. 1619
Butterfly-Medical-Trifold-Brochure-May-2022
Prostate Cancer
Urology Associates if excited to announce that we are participating in the Myovant OPTYX Clinical Study. If you are a Male 18 years or older diagnosed with prostate cancer and initiating treatment with Orgovyx you may be eligible to Participate.
The Myovant OPTYX study is an observational study following males who have been newly prescribed Orgovyx. We will be following newly prescribed patients anywhere from 2-5 years and will be collecting data to understand the safety & health outcomes of patients using this drug.
Interested in participating and want to learn more about enrollment criteria? Email: Research@uradenver.com
Phone: 303-733-8848 ext. 1619